From: The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
Final PAH study sample (N = 504) | |||||||
---|---|---|---|---|---|---|---|
Baseline | Follow-up | p-value | |||||
Mean | SD | Median | Mean | SD | Median | ||
Health care utilization counts | |||||||
Ambulatory visits | 44.95 | 26.86 | 42.58 | 41.62 | 28.71 | 36.00 | <0.001 |
Office visits | 26.17 | 18.74 | 22.31 | 24.63 | 18.01 | 21.00 | 0.010 |
Outpatient visits | 19.19 | 16.56 | 16.22 | 17.34 | 18.49 | 12.00 | <0.001 |
ER visits | 1.56 | 2.95 | 0.00 | 1.55 | 3.17 | 0.00 | 0.032 |
Inpatient stays | 1.38 | 2.03 | 0.00 | 0.91 | 1.59 | 0.00 | <0.001 |